Bridging the Diagnostic Gap: Why CE MDR Class IIb Certification Matters for Global Lung Health

In the high-stakes world of medical imaging, "innovation" is only as valuable as its validation. As healthcare systems grapple with a global shortage of radiologists and a rising burden of respiratory disease, the need for reliable, medical-grade artificial intelligence has never been more urgent.

The Benchmark of Safety and Efficacy

Nexus AI is proud to announce its CE MDR Class IIb certification, a rigorous regulatory milestone that transitions our AI from a promising tool to a clinically validated medical device. Unlike lower-class certifications, Class IIb requires extensive evidence of safety and performance, ensuring that our AI-powered lung health interpretation meets the highest standards for enterprise radiology and population screening.

What This Means for Clinicians

  • Clinically Validated Performance — Our algorithms have demonstrated superior accuracy in detecting abnormalities, as published in The Lancet Digital Health. The TB model achieved an AUC of 0.897, ranked 2nd of 12 CAD AI vendors validated by the Stop TB Partnership.
  • Scalable Triage — By identifying "Normal" versus "Further Investigation Required" (FIR) cases, Nexus AI helps prioritize urgent cases in high-volume centres where reporting backlogs can reach 30%.
  • Global Readiness — This certification unlocks procurement eligibility for EU public health programmes and reflects our commitment to the ISO 13485:2016 Quality Management System.

What CE MDR Class IIb Actually Means

The CE MDR (Medical Device Regulation) framework, implemented by the European Union, is one of the most rigorous regulatory standards in the world for medical devices. Class IIb represents a medium-to-high risk category — the same tier as many implantable devices — requiring manufacturers to demonstrate both clinical performance and ongoing post-market surveillance.

For an AI diagnostic product, this means:

For procurement teams and healthcare systems, CE MDR Class IIb is the clearest signal that an AI product has met the bar required for clinical deployment — not just a promising research prototype, but a validated, accountable medical device.

Learn More About Our Certifications

Speak with our clinical team about procurement, deployment, and regulatory documentation.

Contact Us →